Sorbitrate protocol and dosing

I'll look this up in the medical library for accurate dosing information.
Searching sources...
Reading File
Finding Sources
Searching the Web

Sorbitrate isosorbide dinitrate dosing protocol angina

Reading File
Reading File
Here is a complete reference for Sorbitrate (Isosorbide Dinitrate - ISDN) dosing and protocols:

Sorbitrate (Isosorbide Dinitrate) - Protocol & Dosing

Sorbitrate is a brand name for isosorbide dinitrate (ISDN), an organic nitrate vasodilator available as 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg tablets.

Mechanism of Action

ISDN releases nitric oxide (NO) - NO activates guanylyl cyclase - increases cGMP - relaxes vascular smooth muscle. This produces:
  • Venodilation (reduces preload) - primary effect at low doses
  • Arterial dilation (reduces afterload) - at higher doses
  • Coronary vasodilation - relieves coronary spasm

Indications

  • Angina pectoris (stable, unstable, variant/Prinzmetal)
  • Heart failure (with hydralazine, especially in African Americans with HFrEF)
  • Acute MI (adjunct)

Dosing by Formulation

1. Sublingual Tablets (2.5 mg, 5 mg)

IndicationDoseFrequency
Acute angina relief2.5-5 mg SLMay repeat every 5-10 min; max 3 doses in 15-30 min
Pre-activity prophylaxis2.5-5 mg SL15 min before anticipated exertion
Chronic prophylaxis2.5-10 mg SLEvery 2 hours
  • Onset: 2-5 minutes | Duration: 1-2 hours
  • Starting dose: Do not exceed 5 mg initially (risk of severe hypotension)

2. Immediate-Release Oral Tablets (5, 10, 20, 30, 40 mg)

PurposeInitial DoseMaintenance DoseMax
Angina prophylaxis5-20 mg PO10-40 mg PO480 mg/day
Heart failure20-40 mg PO TIDUp to 40 mg TID-
  • Frequency: 2-3 times daily (eccentric dosing - see Tolerance section below)
  • Typical schedule: 0700 h and 1200 h (bid) or 0700, 1200, 1700 h (tid)
  • Onset: 15-40 minutes | Duration: 4-6 hours

3. Extended-Release / Sustained-Release (40 mg tablets/capsules)

InitialMaintenanceMax
40 mg PO40-80 mg PO160 mg/day
  • Frequency: Twice daily
  • Duration of action: 8-10 hours
  • Caution: Avoid in acute MI or acute HF (adverse effects not easily reversible)

4. Chewable Tablets

  • Dose: 5-10 mg every 2-4 hours
  • Duration: 2-3 hours

5. IV Isosorbide Dinitrate (for severe/rest angina)

  • Reserved for severe, recurrent rest angina
  • Onset is rapid (minutes); effects reverse quickly when infusion stopped

Tolerance Protocol - CRITICAL

Nitrate tolerance develops rapidly with continuous use. This is the most important clinical consideration.
Rule: Always provide a nitrate-free interval of 10-14 hours (usually overnight).
FormulationRecommended ScheduleNitrate-Free Window
IR tablets (bid)0700 and 12001200 to 0700 (19 hrs)
IR tablets (tid)0700, 1200, 17001700 to 0700 (14 hrs)
Extended-releaseInterval must be >18 hrs (exact schedule unclear)Possibly not achievable
Note: Large controlled trials confirm that no ISDN dosing regimen provides more than ~12 hours of continuous anti-anginal efficacy per day. Extended-release products on an eccentric schedule (e.g., 0800 & 1400) were no better than placebo after 4 weeks - Katzung's Basic and Clinical Pharmacology, 16th Ed.

Heart Failure Use (Hydralazine + ISDN)

Used when ACE inhibitors/ARBs are not tolerated, or as add-on in African Americans with HFrEF.
DrugDose
Isosorbide dinitrate20-40 mg PO TID or QID
Hydralazine25-75 mg PO TID or QID
Fixed combination (BiDil)1-2 tablets TID (each tablet = hydralazine 37.5 mg + ISDN 20 mg)
Shown to reduce mortality, HF hospitalizations, and improve quality of life - Goldman-Cecil Medicine.

Key Precautions

SituationGuidance
Absolute CI: PDE-5 inhibitors (sildenafil, tadalafil)Severe hypotension, potentially fatal
Absolute CI: RiociguatSame mechanism - profound hypotension
Hypotension (SBP <90 mmHg)Avoid or use with extreme caution
Volume depletionRisk of severe orthostatic hypotension
Hypertrophic cardiomyopathyCan worsen obstruction and angina
HeadacheVery common (vasodilation); treat with paracetamol/aspirin - usually resolves with continued use
Paradoxical bradycardiaCan occur with nitrate-induced hypotension

Onset & Duration Summary

FormOnsetDuration
SL tablet2-5 min1-2 hours
Oral IR tablet15-40 min4-6 hours
Chewable tablet~5 min2-3 hours
Oral ER tablet30-60 min8-10 hours
Source: Katzung's Basic and Clinical Pharmacology 16th Ed, Table 12-3; Lippincott Illustrated Reviews: Pharmacology; Goldman-Cecil Medicine; Medscape Drug Reference

Bottom line: Start low (5 mg), always use eccentric/asymmetric dosing with a nitrate-free interval to prevent tolerance, and absolutely avoid co-administration with PDE-5 inhibitors.

NTG inj

IV Nitroglycerin (NTG) is typically started at 5-10 mcg/min and titrated up by 5-10 mcg/min every 3-5 minutes based on hemodynamic response, with a usual range of 5-200 mcg/min.
Searching sources...
Finding Sources
Searching the Web

nitroglycerin injection IV infusion protocol dosing mcg/min titration

Reading File
Reading File
Here is the complete IV Nitroglycerin (NTG) injection protocol:

IV Nitroglycerin (NTG) Injection - Protocol & Dosing

Generic: Nitroglycerin | Also known as: Glyceryl trinitrate (GTN) IV | Tridil, Nitro-Bid IV

Indications for IV NTG

  • Unstable angina / NSTE-ACS refractory to sublingual NTG
  • Acute MI with ongoing ischemia or heart failure
  • Acute decompensated heart failure (reduces preload/afterload)
  • Hypertensive emergency (especially with ACS or pulmonary edema)
  • Perioperative hypertension control
  • Induction of controlled hypotension (intraoperatively)

Preparation & Dilution

NOT for direct IV injection - MUST be diluted first
ConcentrationPreparation
Standard (most common): 50 mcg/mL50 mg in 250 mL D5W or 0.9% NaCl
Double concentration: 100 mcg/mL50 mg in 500 mL D5W or NS
200 mcg/mL50 mg in 250 mL (ICU concentrated)
Critical preparation notes:
  • Use glass IV bottles only - NTG is absorbed by many plastics
  • Use non-PVC (polyethylene) tubing - PVC tubing absorbs NTG significantly
  • Do NOT mix with other drugs in the same line
  • Protect from light during infusion
  • Prepare fresh every 24 hours

Dosing Protocol

Step 1 - Before Starting IV NTG

Give sublingual NTG 0.3-0.6 mg (spray or tablet); repeat every 5 min x 3 doses. If symptoms persist after 3 SL doses, start IV infusion. - Harrison's Principles of Internal Medicine, 22nd Ed

Step 2 - Initial Infusion

IndicationStarting Dose
Angina / ACS5-10 mcg/min
Hypertensive emergency10-20 mcg/min
CHF/acute HF0.25-0.5 mcg/kg/min (or 10-20 mcg/min)
Perioperative HTN5-10 mcg/min

Step 3 - Titration

PhaseAction
No response (doses up to 20 mcg/min)Increase by 5 mcg/min every 3-5 min
No response at 20 mcg/minIncrease by 10 mcg/min every 3-5 min
Still no responseMay increase by 20 mcg/min every 3-5 min
Partial response seenReduce increment size; lengthen interval between dose increases

Step 4 - Infusion Rate Quick Reference (50 mg/250 mL = 200 mcg/mL)

Dose (mcg/min)Rate (mL/hr)
51.5
103
206
4012
6018
8024
10030
20060
(For 50 mg/250 mL concentration: mL/hr = mcg/min × 0.3)

Dose Ranges by Indication

IndicationTypical RangeMax
Angina / ACS5-200 mcg/min200 mcg/min
Hypertensive emergency5-400 mcg/min400 mcg/min (provider only)
Perioperative HTN5-100 mcg/min200 mcg/min
Acute HF10-200 mcg/min200 mcg/min
Pediatric (off-label)0.25-0.5 mcg/kg/min, titrate up5 mcg/kg/min

Titration Endpoints (Stop or Reduce)

  • SBP drops to <90 mmHg (absolute stop point)
  • SBP drop of >10 mmHg from baseline (reassess)
  • Heart rate increases significantly
  • Chest pain/ischemia relieved
  • Adequate reduction in SVR or PCWP (in hemodynamic monitoring)
  • Headache, nausea, or symptomatic hypotension

Pharmacokinetics of IV NTG

ParameterValue
Onset1-2 minutes
Peak effect3-5 minutes
Duration3-5 min after stopping infusion
Half-life~1-4 minutes
MetabolismRapid hepatic; to dinitrates & mononitrates
Key property: Effect reverses within minutes of stopping infusion - makes it very titratable.

Hemodynamic Effects by Dose

DosePrimary Effect
Low (<30 mcg/min)Venodilation - reduces preload (PCWP falls)
Moderate (30-100 mcg/min)Coronary vasodilation, mild afterload reduction
High (>100 mcg/min)Arterial dilation - reduces afterload (SVR falls)
At lower dosages, the primary effect is on preload; at higher infusion rates, afterload is reduced. NTG also dilates epicardial coronary vessels and collaterals. - Brenner & Rector's The Kidney

Transitioning Off IV NTG

  • Once pain-free for 12-24 hours, transition to topical or oral nitrates
  • Taper gradually (do not abrupt-stop after prolonged infusion) to avoid rebound ischemia
  • Remove all topical nitrate patches before starting IV NTG

Contraindications

AbsoluteRelative
PDE-5 inhibitors (sildenafil/vardenafil within 24 h; tadalafil within 48 h)Volume depletion
Hypotension (SBP <90 mmHg)Right ventricular infarction
Raised ICP / severe head traumaHypertrophic obstructive cardiomyopathy
Severe aortic stenosis

Tolerance

  • Uninterrupted infusion >24 hours produces tolerance
  • Allow a nitrate-free interval if transitioning to long-term oral nitrate therapy
  • Tolerance does not typically matter clinically during acute short-term IV use

Key Monitoring

  • Continuous BP monitoring (arterial line preferred in ICU/hemodynamic instability)
  • Continuous ECG monitoring
  • Heart rate
  • Urine output
  • PCWP / CVP (if Swan-Ganz catheter in place)
  • Symptoms of headache, dizziness, nausea
Sources: Harrison's Principles of Internal Medicine 22nd Ed; Brenner & Rector's The Kidney; Medscape Drug Reference; Adult Critical Care IV Titration Protocols
This is a shared conversation. Sign in to Orris to start your own chat.